BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28159767)

  • 1. Ticagrelor reversal:
    Calmette L; Martin AC; Le Bonniec B; Zlotnik D; Gouin-Thibault I; Bachelot-Loza C; Gaussem P; Godier A
    J Clin Pathol; 2017 Sep; 70(9):733-739. PubMed ID: 28159767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII and tranexamic acid but not recombinant factor VIIa attenuate tissue plasminogen activator-induced hyperfibrinolysis in human whole blood.
    Dirkmann D; Görlinger K; Gisbertz C; Dusse F; Peters J
    Anesth Analg; 2012 Jun; 114(6):1182-8. PubMed ID: 22104068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.
    Larsen OH; Stentoft J; Radia D; Ingerslev J; Sørensen B
    Br J Haematol; 2013 Jan; 160(2):228-36. PubMed ID: 23151086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel.
    Mazzeffi M; Szlam F; Jakubowski JA; Tanaka KA; Sugidachi A; Levy JH
    Thromb Res; 2013 Jul; 132(1):106-11. PubMed ID: 23664633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential clot stabilising effects of rFVIIa and rFXIII-A2 in whole blood from thrombocytopenic patients and healthy volunteers.
    Johansson PI; Jacobsen N; Viuff D; Olsen EH; Rojkjaer R; Andersen S; Petersen LC; Kjalke M
    Br J Haematol; 2008 Nov; 143(4):559-69. PubMed ID: 18950467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: An in-vitro study.
    Martin AC; Berndt C; Calmette L; Philip I; Decouture B; Gaussem P; Gouin-Thibault I; Samama CM; Bachelot-Loza C; Godier A
    Eur J Anaesthesiol; 2016 May; 33(5):361-7. PubMed ID: 26351831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemostatic Therapy Using Tranexamic Acid and Coagulation Factor Concentrates in a Model of Traumatic Liver Injury.
    Zentai C; van der Meijden PE; Braunschweig T; Hueck N; Honickel M; Spronk HM; Rossaint R; Grottke O
    Anesth Analg; 2016 Jul; 123(1):38-48. PubMed ID: 27192476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
    Sørensen B; Ingerslev J
    Thromb Haemost; 2006 Oct; 96(4):446-53. PubMed ID: 17003921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.
    Mojica Muñoz AK; Jamasbi J; Uhland K; Degen H; Münch G; Ungerer M; Brandl R; Megens R; Weber C; Lorenz R; Siess W
    Thromb Haemost; 2017 Aug; 117(8):1651-1659. PubMed ID: 28569920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal assessment of non-specific hemostatic agents for apixaban reversal.
    Martin AC; Gouin-Thibault I; Siguret V; Mordohay A; Samama CM; Gaussem P; Le Bonniec B; Godier A
    J Thromb Haemost; 2015 Mar; 13(3):426-36. PubMed ID: 25630710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
    Godier A; Parmar K; Manandhar K; Hunt BJ
    J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids.
    Fenger-Eriksen C; Tønnesen E; Ingerslev J; Sørensen B
    Acta Anaesthesiol Scand; 2009 Mar; 53(3):332-8. PubMed ID: 19243319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen depletion after plasma-dilution: impairment of proteolytic resistance and reversal via clotting factor concentrates.
    He S; Johnsson H; Zabczyk M; Hultenby K; Wallén H; Blombäck M
    Thromb Haemost; 2014 Mar; 111(3):417-28. PubMed ID: 24196490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study.
    Skolnick BE; Shenouda M; Khutoryansky NM; Pusateri AE; Gabriel D; Carr ME
    Anesth Analg; 2011 Oct; 113(4):703-10. PubMed ID: 21890888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational and timely haemostatic interventions following cardiac surgery - coagulation factor concentrates or blood bank products.
    Tang M; Fenger-Eriksen C; Wierup P; Greisen J; Ingerslev J; Hjortdal V; Sørensen B
    Thromb Res; 2017 Jun; 154():73-79. PubMed ID: 28437748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro effect of recombinant factor VIIa on coated platelet formation and clot dynamics of stored platelet concentrates.
    Svendsen MS; Kristensen AT; Bochsen L; Salado-Jimena JA; Johansson PI
    Transfusion; 2009 Oct; 49(10):2186-94. PubMed ID: 19527478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
    Martin AC; Le Bonniec B; Fischer AM; Marchand-Leroux C; Gaussem P; Samama CM; Godier A
    Int J Cardiol; 2013 Oct; 168(4):4228-33. PubMed ID: 23928345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model.
    Bonhomme F; Lecompte T; Samama CM; Godier A; Fontana P
    Eur J Anaesthesiol; 2018 Mar; 35(3):208-214. PubMed ID: 29334511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo effect of fibrinogen and factor XIII on clot formation and fibrinolysis in Glanzmann's thrombasthenia.
    Shenkman B; Livnat T; Misgav M; Budnik I; Einav Y; Martinowitz U
    Platelets; 2012; 23(8):604-10. PubMed ID: 22273510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIIa analog has marked effects on platelet function and clot kinetics in blood from patients with hemophilia A.
    Brophy DF; Martin EJ; Nolte ME; Kuhn JG; Barrett JC; Ezban M
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):539-46. PubMed ID: 20581663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.